Cargando…
The effect of histone deacetylase inhibitors on the efficiency of the CRISPR/Cas9 system
The CRISPR/Cas9 technology is a prominent genome-editing tool capable of producing a double-strand break in the genome. However, the modification of hematopoietic stem cells via the homology-directed repair pathway is still inefficient. Therefore, we hypothesize that histone deacetylase inhibitors,...
Autores principales: | Björnson, Ymer, Huang, Codey Y., Rollins, Jaedyn L., Castañeda, Guadalupe, Kaur, Navneet, Yamamoto, Emiko, Johnston, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372373/ https://www.ncbi.nlm.nih.gov/pubmed/37521376 http://dx.doi.org/10.1016/j.bbrep.2023.101513 |
Ejemplares similares
-
The enhancement of CRISPR/Cas9 gene editing using metformin
por: Rollins, Jaedyn L., et al.
Publicado: (2023) -
Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing
por: Liu, Bin, et al.
Publicado: (2020) -
Epigenetic switch reveals CRISPR/Cas9 response to cytosine methylation in plants
por: Raffan, Sarah, et al.
Publicado: (2022) -
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)